This presentation was part of the 2021 clinical symposia, Radiotherapy for Benign Conditions. See Dr. Ogawa’s presentation below from the second session, Radiotherapy for Hyperproliferative Disorders.
XBeam V2: FDA-Approved Treatment Planning Software
The Fastest, Safest Way to Plan Superficial & Orthovoltage Treatment XBeam V2 is the revolutionary, FDA 510(k)-cleared dose planning software designed to automate planning, eliminate risk, and seamlessly integrates with the Concerto system, Xstrahl’s clinical...
